Literature DB >> 8940225

Detection of the hepatitis G virus genome among injecting drug users, homosexual and bisexual men, and blood donors.

K Stark1, U Bienzle, G Hess, A M Engel, B Hegenscheid, V Schluter.   

Abstract

The recently identified hepatitis G virus (HGV) is parenterally transmitted; the impact of sexual transmission is unknown. Moreover, it is unclear what proportion of HGV-infected persons may develop persistent viremia. Sera from injecting drug users (IDUs), non-drug-injecting homosexual and bisexual men with high levels of sexual risk behavior, and blood donors were tested for HGV RNA and hepatitis C virus (HCV) RNA by reverse transcriptase-polymerase chain reaction and for antibodies to human immunodeficiency virus, hepatitis B virus, and HCV. HGV RNA was detected in 33% of IDUs (n = 130), 11% of homosexual and bisexual men (n = 101), and 2% of blood donors (n = 90). HGV RNA seroprevalence significantly decreased with increasing time since first drug injection, whereas the seroprevalences of both HCV RNA and anti-HCV antibody increased. Thus, a high proportion of HGV-infected persons may clear the virus and develop protective antibodies. The relatively high HGV RNA prevalence among non-drug-injecting homosexual and bisexual men indicates that sexual contact may be another important route of HGV transmission.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8940225     DOI: 10.1093/infdis/174.6.1320

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  24 in total

1.  Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses.

Authors:  T Laskus; M Radkowski; L F Wang; H Vargas; J Rakela
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Identification of hepatitis G virus particles in human serum by E2-specific monoclonal antibodies generated by DNA immunization.

Authors:  S Schmolke; M Tacke; U Schmitt; A M Engel; B Ofenloch-Haehnle
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  Hepatitis G virus coinfection in chronic hepatitis B and C patients in Poland.

Authors:  M Radkowski; W Stańczak; B Walewska-Zielecka; T Loch; J Cianciara; L F Wang; T Laskus
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

4.  Heterosexual transmission of GB virus C/hepatitis G virus infection to non-intravenous drug-using female prostitutes in Fukuoka, Japan.

Authors:  Y Sawayama; J Hayashi; Y Etoh; H Urabe; K Minami; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1999-10       Impact factor: 3.199

5.  Immunoreactivity to putative B-cell epitopes of hepatitis G virus polyprotein in viremic and nonviremic subjects.

Authors:  P Toniutto; C Fabris; F Barbone; S G Tisminetzky; D Liani; T Galai; G Barillari; F Biffoni; V Gasparini; M Pirisi
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

Review 6.  GB virus C/hepatitis G virus (GBV-C/HGV): still looking for a disease.

Authors:  M Sathar; P Soni; D York
Journal:  Int J Exp Pathol       Date:  2000-10       Impact factor: 1.925

Review 7.  Beyond Cytomegalovirus and Epstein-Barr Virus: a Review of Viruses Composing the Blood Virome of Solid Organ Transplant and Hematopoietic Stem Cell Transplant Recipients.

Authors:  Marie-Céline Zanella; Samuel Cordey; Laurent Kaiser
Journal:  Clin Microbiol Rev       Date:  2020-08-26       Impact factor: 26.132

8.  Investigation of saliva, faeces, urine or semen samples for the presence of GBV-C RNA.

Authors:  Q R Eugenia; Q R Ana; M Carmen
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

9.  Age-dependent acquisition of hepatitis G virus/GB virus C in a nonrisk population: detection of the virus by antibodies.

Authors:  H H Feucht; M Schröter; B Zöllner; S Polywka; R Laufs
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

10.  HGV/GBV-C in liver tissue and in sera from patients with chronic hepatitis C.

Authors:  P Fabris; M R Biasin; D Infantolino; L Romanó; P Benedetti; G Tositti; G P Pellizzer; A R Zanetti; C Stecca; G Marchelle; F de Lalla
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.